Taysha Gene Therapies (TSHA) Depreciation and Depletion (2020 - 2026)
Taysha Gene Therapies (TSHA) reported Depreciation and Depletion of $400,000 for Q2 2026, up 33.3% from $300,000 a year earlier and up 33.3% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Depreciation and Depletion (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Taysha Gene Therapies' Depreciation and Depletion came in at $1.2 million, down 0.4% year-over-year; for FY2025, it was $1.15 million, down 8.0% from FY2024.
- Depreciation and Depletion has a five-year compound annual growth rate of 163.6% (FY2020 to FY2025).
- By year, Depreciation and Depletion came in at $1.25 million in FY2024 (-11.1%), $1.4 million in FY2023 (+16.7%), $1.2 million in FY2022 (+140.0%) and $500,000 in FY2021.
- Year over year, Depreciation and Depletion gained in 1 of the last eight quarters, with an average decline of 4.0%.
- The high point for year-over-year Depreciation and Depletion in five years was Q1 2022 (growth of 837.5%); the low point was Q3 2025 (a decline of 33.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $300,000 (Q1 2026), $299,000 (Q4 2025) and $200,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Taysha Gene Therapies | 1.51 Bn | 1.51 Bn | - | 400,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 299,000.00 |
| Sep 30, 2025 | 200,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | 304,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 325,000.00 |
| Dec 31, 2023 | 395,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 400,000.00 |
| Mar 31, 2023 | 331,000.00 |
| Dec 31, 2022 | 390,000.00 |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 300,000.00 |
| Dec 31, 2021 | 200,000.00 |
| Sep 30, 2021 | 200,000.00 |
API Access
Taysha Gene Therapies Depreciation and Depletion API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-depletion", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();